61 related articles for article (PubMed ID: 18774472)
1. Surveillance for renal cell carcinoma: why and how? When and how often?
Klatte T; Lam JS; Shuch B; Belldegrun AS; Pantuck AJ
Urol Oncol; 2008; 26(5):550-4. PubMed ID: 18774472
[TBL] [Abstract][Full Text] [Related]
2. Current evidence on screening for renal cancer.
Usher-Smith J; Simmons RK; Rossi SH; Stewart GD
Nat Rev Urol; 2020 Nov; 17(11):637-642. PubMed ID: 32860009
[TBL] [Abstract][Full Text] [Related]
3. Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma.
Diaz de Leon A; Pirasteh A; Costa DN; Kapur P; Hammers H; Brugarolas J; Pedrosa I
Radiographics; 2019; 39(4):998-1016. PubMed ID: 31199711
[TBL] [Abstract][Full Text] [Related]
4. [Follow-up of renal cell carcinoma in a nonmetastatic stage].
Szabados B; Foller S; Schulz GB; Staehler M; Grimm MO; Stief CG; Casuscelli J
Urologe A; 2019 Jan; 58(1):65-76. PubMed ID: 30627750
[TBL] [Abstract][Full Text] [Related]
5. Follow-up after curative treatment of localised renal cell carcinoma.
Dabestani S; Marconi L; Kuusk T; Bex A
World J Urol; 2018 Dec; 36(12):1953-1959. PubMed ID: 29767327
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy".
Hoerner-Rieber J; Duma M; Blanck O; Hildebrandt G; Wittig A; Lohaus F; Flentje M; Mantel F; Krempien R; Eble MJ; Kahl KH; Boda-Heggemann J; Rieken S; Guckenberger M
J Thorac Dis; 2017 Nov; 9(11):4512-4522. PubMed ID: 29268521
[TBL] [Abstract][Full Text] [Related]
7. Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.
Baum YS; Patil D; Huang JH; Spetka S; Torlak M; Nieh PT; Alemozaffar M; Ogan K; Master VA
Asian J Urol; 2016 Jan; 3(1):20-25. PubMed ID: 29264158
[TBL] [Abstract][Full Text] [Related]
8. Imaging and Screening of Kidney Cancer.
Diaz de Leon A; Pedrosa I
Radiol Clin North Am; 2017 Nov; 55(6):1235-1250. PubMed ID: 28991563
[TBL] [Abstract][Full Text] [Related]
9. Displacement of the Spleen Mimicking Renal Cell Cancer Recurrence Post-Nephrectomy: A Case Report.
Emanuels CS; Timmerman KD; Aijaz T; Nguyen TC; Jest N; Drane WE; Gilbert SM; Crispen PL; Su LM; Deitte LA; Dang LH
J Kidney Cancer VHL; 2015; 2(3):130-133. PubMed ID: 28326267
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary metastasectomy in renal cell carcinoma].
Macherey S; Kauffmann C; Heidenreich A; Doerr F; Wahlers T; Hekmat K
Urologe A; 2017 Aug; 56(8):1025-1030. PubMed ID: 28280862
[TBL] [Abstract][Full Text] [Related]
11. Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients.
Kuijpers YA; Meijer RP; Jonges GN; de Jong J; Bosch JL; Horenblas S; Bex A
World J Urol; 2016 Aug; 34(8):1073-9. PubMed ID: 27055532
[TBL] [Abstract][Full Text] [Related]
12. Postoperative renormalization of C-reactive protein with adjuvant lienal polypeptide and its association with tumour recurrence in T1 clear cell renal cell carcinoma.
Guo Y; Hu Q; Sun C; Gu B; Xu K; Xia G
J Int Med Res; 2016 Jun; 44(3):620-6. PubMed ID: 26944387
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Neutrophil-to-Lymphocyte Ratio and Neutrophilia Are Independent Predictors of Recurrence in Patients with Localized Papillary Renal Cell Carcinoma.
Huang J; Dahl DM; Dong L; Liu Q; Cornejo K; Wang Q; Wu S; Feldman AS; Huang Y; Xue W; Wu CL
Biomed Res Int; 2015; 2015():891045. PubMed ID: 26448948
[TBL] [Abstract][Full Text] [Related]
14. Surgical resection of recurrent inferior vena cava tumor following radical nephrectomy for renal cell carcinoma: A case report.
Li G; Zhang Z; Xie D; Ye N; Yu D
Oncol Lett; 2015 Jul; 10(1):111-114. PubMed ID: 26170985
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease.
Campbell L; Al-Jayyoussi G; Gutteridge R; Gumbleton N; Griffiths R; Gumbleton S; Smith MW; Griffiths DF; Gumbleton M
J Transl Med; 2013 Oct; 11():255. PubMed ID: 24119769
[TBL] [Abstract][Full Text] [Related]
16. ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma.
Arias-González L; Moreno-Gimeno I; del Campo AR; Serrano-Oviedo L; Valero ML; Esparís-Ogando A; de la Cruz-Morcillo MÁ; Melgar-Rojas P; García-Cano J; Cimas FJ; Hidalgo MJ; Prado A; Callejas-Valera JL; Nam-Cha SH; Giménez-Bachs JM; Salinas-Sánchez AS; Pandiella A; del Peso L; Sánchez-Prieto R
Neoplasia; 2013 Jun; 15(6):649-59. PubMed ID: 23730213
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10 years after initial treatment.
Kyoda Y; Kobayashi K; Hirobe M; Shindo T; Fukuta F; Hashimoto K; Tanaka T; Tonooka A; Kitamura H; Takahashi S; Masumori N; Hasegawa T; Tsukamoto T
Int J Clin Oncol; 2014 Feb; 19(1):146-51. PubMed ID: 23404486
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy.
Cross BW; Johnson TV; Derosa AB; Ogan K; Pattaras JG; Nieh PT; Kucuk O; Harris WB; Master VA
Int J Surg Oncol; 2012; 2012():524981. PubMed ID: 22900160
[TBL] [Abstract][Full Text] [Related]
19. Predictive models for the practical management of renal cell carcinoma.
Lee LS; Tan MH
Nat Rev Urol; 2012 Jan; 9(2):73-84. PubMed ID: 22231290
[TBL] [Abstract][Full Text] [Related]
20. Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma.
Michigan A; Johnson TV; Master VA
Mol Diagn Ther; 2011 Aug; 15(4):229-34. PubMed ID: 21756006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
